These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 27334504)
1. A Feline-Specific Anti-Nerve Growth Factor Antibody Improves Mobility in Cats with Degenerative Joint Disease-Associated Pain: A Pilot Proof of Concept Study. Gruen ME; Thomson AE; Griffith EH; Paradise H; Gearing DP; Lascelles BD J Vet Intern Med; 2016 Jul; 30(4):1138-48. PubMed ID: 27334504 [TBL] [Abstract][Full Text] [Related]
2. In Vitro and In Vivo Characterization of a Fully Felinized Therapeutic Anti-Nerve Growth Factor Monoclonal Antibody for the Treatment of Pain in Cats. Gearing DP; Huebner M; Virtue ER; Knight K; Hansen P; Lascelles BD; Gearing RP; Drew AC J Vet Intern Med; 2016 Jul; 30(4):1129-37. PubMed ID: 27306920 [TBL] [Abstract][Full Text] [Related]
3. A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain. Lascelles BD; Knazovicky D; Case B; Freire M; Innes JF; Drew AC; Gearing DP BMC Vet Res; 2015 Apr; 11():101. PubMed ID: 25926287 [TBL] [Abstract][Full Text] [Related]
5. Frunevetmab, a felinized anti-nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats. Gruen ME; Myers JAE; Tena JS; Becskei C; Cleaver DM; Lascelles BDX J Vet Intern Med; 2021 Nov; 35(6):2752-2762. PubMed ID: 34724255 [TBL] [Abstract][Full Text] [Related]
6. Detection of clinically relevant pain relief in cats with degenerative joint disease associated pain. Gruen ME; Griffith E; Thomson A; Simpson W; Lascelles BD J Vet Intern Med; 2014; 28(2):346-50. PubMed ID: 24512390 [TBL] [Abstract][Full Text] [Related]
7. Reliability and discriminatory testing of a client-based metrology instrument, feline musculoskeletal pain index (FMPI) for the evaluation of degenerative joint disease-associated pain in cats. Benito J; Depuy V; Hardie E; Zamprogno H; Thomson A; Simpson W; Roe S; Hansen B; Lascelles BD Vet J; 2013 Jun; 196(3):368-73. PubMed ID: 23369382 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Clinical Metrology Instrument in Dogs with Osteoarthritis. Muller C; Gaines B; Gruen M; Case B; Arrufat K; Innes J; Lascelles BD J Vet Intern Med; 2016 May; 30(3):836-46. PubMed ID: 26971876 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of an Anti-nerve Growth Factor Antibody (Frunevetmab) for the Treatment of Degenerative Joint Disease-Associated Chronic Pain in Cats: A Multisite Pilot Field Study. Gruen ME; Myers JAE; Lascelles BDX Front Vet Sci; 2021; 8():610028. PubMed ID: 34124212 [No Abstract] [Full Text] [Related]
10. Evaluation of a nutritional supplement for the alleviation of pain associated with feline degenerative joint disease: a prospective, randomized, stratified, double-blind, placebo-controlled clinical trial. Cunningham R; Gruen ME; Thomson A; Lascelles BDX J Feline Med Surg; 2022 Oct; 24(10):962-974. PubMed ID: 34719996 [TBL] [Abstract][Full Text] [Related]
11. Caregiver placebo effect in analgesic clinical trials for cats with naturally occurring degenerative joint disease-associated pain. Gruen ME; Dorman DC; Lascelles BDX Vet Rec; 2017 May; 180(19):473. PubMed ID: 28270539 [TBL] [Abstract][Full Text] [Related]
13. Long-term analgesic effect of a single dose of anti-NGF antibody on pain during motion without notable suppression of joint edema and lesion in a rat model of osteoarthritis. Ishikawa G; Koya Y; Tanaka H; Nagakura Y Osteoarthritis Cartilage; 2015 Jun; 23(6):925-32. PubMed ID: 25677108 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and Immunogenicity of Frunevetmab in Osteoarthritic Cats Following Intravenous and Subcutaneous Administration. Walters RR; Boucher JF; De Toni F Front Vet Sci; 2021; 8():687448. PubMed ID: 34179175 [TBL] [Abstract][Full Text] [Related]
15. Refinement of the Feline Musculoskeletal Pain Index (FMPI) and development of the short-form FMPI. Enomoto M; Lascelles BDX; Robertson JB; Gruen ME J Feline Med Surg; 2022 Feb; 24(2):142-151. PubMed ID: 34002643 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of client-specific outcome measures and activity monitoring to measure pain relief in cats with osteoarthritis. Lascelles BD; Hansen BD; Roe S; DePuy V; Thomson A; Pierce CC; Smith ES; Rowinski E J Vet Intern Med; 2007; 21(3):410-6. PubMed ID: 17552444 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a therapeutic diet for feline degenerative joint disease. Lascelles BD; DePuy V; Thomson A; Hansen B; Marcellin-Little DJ; Biourge V; Bauer JE J Vet Intern Med; 2010; 24(3):487-95. PubMed ID: 20337921 [TBL] [Abstract][Full Text] [Related]
18. Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats. Enomoto M; Mantyh PW; Murrell J; Innes JF; Lascelles BDX Vet Rec; 2019 Jan; 184(1):23. PubMed ID: 30368458 [TBL] [Abstract][Full Text] [Related]
19. Analgesic efficacy of an oral transmucosal spray formulation of meloxicam alone or in combination with tramadol in cats with naturally occurring osteoarthritis. Monteiro BP; Klinck MP; Moreau M; Guillot M; Steagall PV; Edge DK; Pelletier JP; Martel-Pelletier J; Gauvin D; Del Castillo JR; Troncy E Vet Anaesth Analg; 2016 Nov; 43(6):643-651. PubMed ID: 26913836 [TBL] [Abstract][Full Text] [Related]
20. Amantadine in a multimodal analgesic regimen for alleviation of refractory osteoarthritis pain in dogs. Lascelles BD; Gaynor JS; Smith ES; Roe SC; Marcellin-Little DJ; Davidson G; Boland E; Carr J J Vet Intern Med; 2008; 22(1):53-9. PubMed ID: 18289289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]